COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
- 1 February 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9204) , 646-648
- https://doi.org/10.1016/s0140-6736(99)12031-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Heme oxygenase: A novel target for the modulation of inflammatory responseNature Medicine, 1996
- Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.Proceedings of the National Academy of Sciences, 1994
- Towards a better aspirinNature, 1994
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.Journal of Clinical Investigation, 1990
- EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON THE COURSE OF OSTEOARTHRITISThe Lancet, 1989
- Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentineThe Journal of Pathology, 1971
- Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory DrugsExperimental Biology and Medicine, 1962